Form 4 for ACET Adicet Bio, Inc.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001209191-22-050372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-09-16 | 2022-09-14 | ACET | Schor Chen | Pres, CEO, Dir | S - Sale | $18.00 | -952 | 138.7K | -0.7% | -$17.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-14 | S | D | 952 | $18.00 | 138,737 | I See Footnote | — | — | (F2) Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee. |